AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 72 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $187,479 | -5.5% | 646,478 | +46.6% | 0.03% | -27.9% |
| Q4 2022 | $198,333 | -84.5% | 440,837 | +135.5% | 0.04% | -75.4% |
| Q2 2019 | $1,282,000 | -83.7% | 187,206 | -80.8% | 0.18% | -75.6% |
| Q1 2019 | $7,849,000 | +74.7% | 975,000 | +62.5% | 0.72% | +41.2% |
| Q4 2018 | $4,494,000 | -28.1% | 600,000 | -8.1% | 0.51% | -29.4% |
| Q3 2018 | $6,250,000 | +16.0% | 653,112 | +28.3% | 0.72% | -3.4% |
| Q2 2018 | $5,386,000 | – | 509,118 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 340,679 | $3,604,000 | 1.39% |
| Nantahala Capital Management | 2,213,052 | $23,414,000 | 0.95% |
| SCP Investment, LP | 156,137 | $1,652,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 509,118 | $5,386,000 | 0.74% |
| DELTEC ASSET MANAGEMENT LLC | 151,781 | $1,606,000 | 0.32% |
| Rock Springs Capital Management LP | 650,000 | $6,877,000 | 0.26% |
| Orbimed Advisors | 1,865,524 | $19,737,000 | 0.24% |
| Baker Brothers Advisors | 1,387,872 | $14,684,000 | 0.11% |
| EAM Investors, LLC | 56,726 | $600,000 | 0.10% |
| Stanley-Laman Group, Ltd. | 35,036 | $371,000 | 0.08% |